Additionally, CYTOR has been implicated in breast cancer resistance to tamoxifen, where it enhances tumor cell survival by aberrantly activating the MAPK/ERK signaling cascade, a key pathway in tumor proliferation and drug resistance [4, 25]. This evidence concerns the gene CYTOR and breast carcinoma.